Herpes Marker Testing Market: Key Trends & Geographical Analysis
Herpes Marker Testing Market: Overview
Owing to the high prevalence of herpes simplex virus of both types, HSV- 1 and HSV- 2, the demand for herpes marker testing is receiving a stimulus. According to estimates of Centers for Disease Control and Prevention, each year in the U.S., 776,000 people get new genital herpes infections. Countrywide, 11.9% of the population aged between 14 and 49 years have HSV-2 infection, with African- American female population mainly affected.
Read Report Overview - https://www.transparencymarketresearch.com/herpes-marker-testing-market.html
Furthermore, according to data presented by the Public Health Agency of Canada, prevalence of HSV-1 infection is higher than HSV-2 in most parts of the world. The data also shows seroprevalence in adults is above 70% in developed countries, and almost 100% in developing and underdeveloped countries.
The study on the herpes marker testing market provides a pinpoint analysis of demand dynamics, growth indices, and vendor landscape of the said market for the 2015 – 2023 forecast period.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5510
Herpes Marker Testing Market: Key Trends
Growth of herpes marker testing market stems from ubiquity of herpes virus and asymptomatic nature of the infection. More than 80% herpes infections are asymptomatic, because of which physicians depend on diagnostic tests for correct diagnosis and treatment. Some symptoms of herpes infection are blistering sores, swollen lymph nodes, pain during urination, and fever.
Request for Analysis of COVID-19 Impact on Herpes Marker Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=5510
High risk of contraction of herpes virus by close contact with an infected individual is pushing the growth of herpes marker testing market. The virus is transmitted through body fluids such as blood, saliva, and semen. Some studies suggest herpes virus is transmitted through breast milk.
Less number of diagnostic tests available for herpes simplex virus (HSV) is another factor behind growth of herpes marker testing market. Currently, there are four tests available for HSV biomarker testing, namely, antigen tests, cell culture tests, polymerase chain reaction, and antibody tests. Of all, polymerase chain reaction tests are most accurate for diagnosis of HSV. Whilst, cell culture tests have chance of false negative results, and are time consuming too. This arouses need for new diagnostic tests for HSV biomarker testing.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=5510
Herpes Marker Testing Market: Geographical Analysis
North America, among all, is the forefront in terms of clinical trials for herpes marker testing. Medical insurance coverage for HSV testing and presence of state-of-the-art testing facilities are other factors that make the region prominent. High awareness among individuals to seek medical testing for symptomatic HSV also accounts for substantial revenue of the region in the overall herpes marker testing market. Furthermore, higher seroprevalence of HSV and large number of HIV patients are some other factors that pushes growth of North America herpes marker testing market.
On the other hand, limited knowledge of HSV among individuals of developing countries is a factor for small revenue of Asia Pacific herpes marker testing market. Due to the economic conditions and limited medical facilities, cost-effective diagnosis tests are in high demand in developing countries of Asia Pacific.
Pre Book Herpes Marker Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=5510<ype=S
Herpes Marker Testing Market: Competitive Landscape
Keen players in the herpes marker testing market are making strides for diagnostic tests for HSV1- and HSV- 2. R&D and clinical trials is the focus of top players in the herpes market testing market. In 2014, Simplexa HSV 1 and HSV 2 direct molecular test by Quest Diagnostics are the first ones to receive U.S. FDA’s approval. The Simplexa test is the first one approved by U.S. FDA that enables qualitative differentiation and detection of HSV-1 and HSV- 2 in cerebrospinal fluid.
Some other top players in the herpes marker testing market are Trinity Biotech, Biohelix, Focus Diagnostics, DiaSorin, Roche, Thermo Fisher Scientific, and Enzo Life Sciences.
Browse more Reports by Transparency Market Research:
Turner Syndrome Treatment Market: https://www.transparencymarketresearch.com/turner-syndrome-treatment-market.html
Intraoral Cameras Market: https://www.transparencymarketresearch.com/intraoral-cameras-market.html
Self-assembling Vaccines Market: https://www.transparencymarketresearch.com/selfassembling-vaccines-market.html
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Mr. Rohit Bhisey
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453